Article | November 14, 2023

The Post-Pandemic Supply Chain: Improving Resilience Via Value Chains

By Andrew Goldman, Head of Business Continuity Management, Lynn Stephenson, PhD., Senior Marketing Manager, Supply Security, and Oliver Prince, PhD., Senior Consultant, Strategy Optimization

GettyImages-1331571740-supply-chain-sourcing-logistics-tracking

The COVID-19 pandemic underscored the vulnerability of global supply chains, revealing the fragility of lean manufacturing techniques and ‘just-in-time’ inventory models. The strain of supply chain disruptions particularly impacted the pharmaceutical industry as it raced to eradicate the virus. Post-pandemic, supply chain resilience is top of mind. The industry is striving to fortify against future supply chain disruptions by developing a robust plan for the unexpected, involving stronger risk management and focus on the value of customers. The emphasis on value chains over supply chains, driven by customer-centric approaches, marks a transformative post-pandemic shift.

Strengthening the resilience of biopharmaceutical supply chains is not merely a business imperative, for patients around the world are relying on the timely delivery of life-changing and life-saving treatments. In this article, you will explore lessons learned from the pandemic, the concept of supply chain resilience, what to look for in a supplier, and much more.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online